资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.

Br. J. Pharmacol.. 2018;

Lê Vuong Ba，Riteau Béatrice，Alessi Marie-Christine，Couture Christian，Jandrot-Perrus Martine，Rhéaume Chantal，Hamelin Marie-ève，Boivin

Products/Services Used	Details	Operation
Recombinant Proteins	) per mL. Cytotoxicity assessment The CC50 concentrations of PAR1 agonist TFLLR-NH2 (GenScript	Get A Quote

摘要

Protease-activated receptor 1 (PAR1) has been demonstrated to be involved in the pathogenesis of viral diseases. However， its role remains controversial. The goal of our study was to investigate the contribution of PAR1 to respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) infections.